Skip to main content
. 2023 Mar 15;14(3):290–298. doi: 10.4239/wjd.v14.i3.290

Table 2.

Family member and perinatal antecedents in the two study groups, n (%)

Variable Patients with T2DM (2013)
Patients with T2DM (2018)
P value
n = 47
n = 104
History of T2DM, in relatives of 1° and 2° [n (%)] 24 (51.1) 79 (75.9) 0.002
Antecedent of obesity in relatives of 1° and 2° [n (%)] 31 (65.9) 84 (80.7) 0.048
Antecedent of DM [n (%)] 7 (14.9) 9 (8.7) 0.249
Weight at birth (kg) 3.31 ± 0.66 3.03 ± 0.44 0.005
Socioeconomic statusa,b
Upper 5 (10.6) 6 (5.8)
Upper-middle 6 (12.8) 6 (5.8)
Middle 6 (12.8) 18 (17.3) 0.023
Lower-middle 16 (34) 18 (17.3)
Upper-Lower 10 (21.3) 28 (26.9)
Lower 4 (8.5) 28 (26.9)
Comorbidities
Hypercholesterolemia [n (%)] 22 (46.8) 29 (27.9) 0.023
Hypertriglyceridemia 27 (57.4) 78 (75.0) 0.030
Hypoalphalipoproteinemia 19 (40.4) 16 (15.4) 0.001
Hepatic steatosis 6 (12.8) 22 (21.2) 0.219
Arterial hypertension 5 (10.6) 22 (22.3) 0.021
a

AMAI/NSE 8 × 7 model.

b

Pearson χ2 test.

T2DM: Type 2 diabetes mellitus.